Japan Digestive System Disorder Medicine Sales is set to reach $4,440 Million by 2026 from $4,540 Million 2021, increased 4.3% per year. Since 2017, the market grew 3.9% year on year reaching $36,680 Million. The country came in number 2 in 2021, Germany came ahead $4,540 Million. Japan, South Korea and Canada respectively ranked numbers 2, 3 and 4 in this ranking.
How does Japan rank in Alimentary Tract and Metabolism Medicine Sales?
| # | 9 Countries | Million US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Canada | 5,850 | 2023 | +9.88% | +12.08% | View data |
| 2 | 2 Japan | 4,940 | 2023 | +0.079% | +7.75% | |
| 3 | 3 United Kingdom | 2,720 | 2023 | +0.99% | +0.55% | View data |
| 4 | 4 Belgium | 926 | 2023 | +2.24% | +2.71% | View data |
| 5 | 5 Austria | 511.2 | 2023 | +5.36% | +6.48% | View data |
